Comet Therapeutics focuses on the development of a portfolio of drug candidates that centers around efforts to re-engineer CoEnzyme-A (CoA). Its platform has numerous applications including metabolic disorders, neuro-metabolic diseases, immuno-metabolic conditions and other life-threatening diseases.